Press Releases

Summary Toggle Chembio Sponsors 28th Annual AIDS Walk New York as Co-Chair Advocate

May 17, 2013

Company Voices Support for U.S. Preventive Services Task Force Recommendations for Routine HIV Testing of All Adults Aged 15-65

Read more

Chembio Sponsors 28th Annual AIDS Walk New York as Co-Chair Advocate 37.3 KB
Summary Toggle Chembio Enters Into Six-Month Follow-On Contract With CDC Contractor for Development of Rapid, Point-of-Care Influenza Immunity Test

May 16, 2013

MEDFORD, N.Y. , May 16, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, announces that the Company has entered into a follow-on, milestone-based development agreement with a private contracting organization
Read more

Chembio Enters Into Six-Month Follow-On Contract With CDC Contractor for Development of Rapid, Point-of-Care Influenza Immunity Test 35.3 KB
Summary Toggle Chembio's DPP(R) HIV-Syphilis Multiplex Test Demonstrates 100% Sensitivity and Specificity in Evaluation by Mexico's Institute of Epidemiological Diagnosis and Reference

May 14, 2013

MEDFORD, N.Y., May 14, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announces receipt of an evaluation report from Mexico's Institute of Epidemiological Diagnosis and Reference (InDRE) regarding the Company's
Read more

Chembio's DPP(R) HIV-Syphilis Multiplex Test Demonstrates 100% Sensitivity and Specificity in Evaluation by Mexico's Institute of Epidemiological Diagnosis and Reference 34.3 KB
Summary Toggle Chembio Diagnostics Reports First Quarter 2013 Financial Results

May 9, 2013

Conference Call Begins at 10:00 a.m. Eastern Time Today

Read more

Chembio Diagnostics Reports First Quarter 2013 Financial Results 48 KB
Summary Toggle Chembio Diagnostics Supports Recent USPSTF Routine Testing Recommendations

May 2, 2013

MEDFORD, N.Y., May 2, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today announced the Company's support for the U.S. Preventive Services Task (USPSTF) new recommendations for HIV testing of all adults aged
Read more

Chembio Diagnostics Supports Recent USPSTF Routine Testing Recommendations 34.1 KB
Summary Toggle Chembio to Host Conference Call to Discuss First Quarter 2013 Financial Results

Apr 25, 2013

Conference Call Scheduled for Thursday, May 9th At 10:00 a.m. Eastern Time

Read more

Chembio to Host Conference Call to Discuss First Quarter 2013 Financial Results 35.5 KB
Summary Toggle Chembio Commences CLIA Waiver Studies for DPP(R) HIV 1/2 Assay

Apr 18, 2013

MEDFORD, N.Y. , April 18, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) a leader in point-of-care diagnostic tests ("POCT"), announces that the Clinical Laboratory Improvement Amendments (CLIA) waiver studies for its DPP ® HIV 1/2 Assay have commenced.
Read more

Chembio Commences CLIA Waiver Studies for DPP(R) HIV 1/2 Assay 36.1 KB
Summary Toggle Chembio Announces Closing of $6 Million Public Offering of Common Stock

Apr 3, 2013

MEDFORD, N.Y. , April 3, 2013 (GLOBE NEWSWIRE) -- CHEMBIO DIAGNOSTICS, INC. (Nasdaq:CEMI) today announced the closing of its previously announced underwritten public offering of 1,200,000 shares of its common stock. The price per share of common stock sold in the offering was $5 per share. The net
Read more

Chembio Announces Closing of $6 Million Public Offering of Common Stock 35.1 KB
Summary Toggle Chembio Announces Pricing of $6.0 Million Public Offering of Common Stock

Mar 28, 2013

MEDFORD, N.Y., March 28, 2013 (GLOBE NEWSWIRE) -- CHEMBIO DIAGNOSTICS, INC. (Nasdaq:CEMI) today announced that it has priced an underwritten public offering of 1,200,000 shares of its common stock. Each share of common stock sold in this offering will be sold for $5.00 per share. The net proceeds
Read more

Chembio Announces Pricing of $6.0 Million Public Offering of Common Stock 33.6 KB
Summary Toggle Chembio Announces Public Offering of Common Stock

Mar 27, 2013

MEDFORD, N.Y. , March 27, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) today announced an underwritten public offering of its common stock. The proceeds of the offering will be used for business expansion and working capital. The Company expects to close the transaction, subject
Read more

Chembio Announces Public Offering of Common Stock 34.9 KB